evidence card · artificial_sweeteners_cardiometabolic_safe
Non-nutritive sweeteners at typical intakes do not cause insulin spikes, blood-sugar issues, or measurable cardiometabolic harm
H3
≈ mixed
stakes moderate
1 post scored
·
across 1 account
·
2 sources
Summary
RCTs on insulin/glucose acute responses are mostly null for aspartame/sucralose/stevia at normal doses. Substitution of SSBs with NNS is associated with weight-loss benefit vs SSBs. WHO 2023 nonetheless suggests against NNS for weight management based on long-term observational concerns.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
general adults
Intervention
replacing sugar-sweetened beverages with NNS-sweetened
Outcome
insulin, glucose, weight, CV outcomes
Not supported for
- claim NNS are entirely benign for everyone; WHO 2023 guidance advises against using NNS for weight control